Charter 2 & 3 Communicating risk in breast cancer

Back

Charter 2 & 3 Communicating risk in breast cancer

Including communication of genomic test results, and the potential benefits and harms of treatments

Professor Sir David Spiegelhalter &
Professor Dame Lesley Fallowfield